tiprankstipranks
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics, Inc. (ALLR) Cash flow

109 Followers

Allarity Therapeutics, Inc. Cash Flow

ALLR's free cash flow for Q2 2023 was $-5.38M. For the 2023 fiscal year, ALLR's free cash flow was decreased by $-2.44M and operating cash flow was $-5.38M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -13.52M$ -16.82M$ -14.59M$ -7.25M$ -10.11M
Investing Cash Flow
$ -18.00K$ 791.00K$ 1.00M$ -3.00K$ 229.00K
Financing Cash Flow
$ 11.47M$ -1.31M$ 33.82M$ 6.03M$ 11.20M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 4.67M$ 2.03M$ 20.53M$ 298.00K$ 1.52M
Income Tax Paid Supplemental Data
$ 17.00K$ 12.00K$ 118.00K$ 0.00$ 22.00K
Interest Paid Supplemental Data
$ 101.00K$ 85.00K$ 262.00K$ 40.00K$ 47.00K
Issuance Of Capital Stock
--$ 32.13M$ 3.70M$ 13.56M
Issuance Of Debt
$ 16.97M$ 1.00M$ 969.00K$ 3.00M$ 8.66M
Repayment Of Debt
$ -3.70M-$ -3.03M$ -533.00K$ -5.11M
Free Cash Flow
$ -12.73M$ -16.03M$ -13.58M$ -7.25M$ -10.12M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Allarity Therapeutics, Inc. Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis